Publications

Export 36 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Aged, 80 and over  [Clear All Filters]
2018
Vasiliadis HM, Milan R, Guerra SGontijo, MJ Fleury.  2018.  Patient and health system factors associated with hospital readmission in older adults without cognitive impairment.. Gen Hosp Psychiatry. 53:44-51.
2016
Chung JKu, Plitman E, Nakajima S, M Chakravarty M, Caravaggio F, Takeuchi H, Gerretsen P, Iwata Y, Patel R, Mulsant BH et al..  2016.  Depressive Symptoms and Small Hippocampal Volume Accelerate the Progression to Dementia from Mild Cognitive Impairment.. J Alzheimers Dis. 49(3):743-54.
Gordon MForrest, Lenderking WR, Duhig A, Chandler J, J Lundy J, Miller DS, Piault-Louis E, Doody RS, Galasko D, Gauthier S et al..  2016.  Development of a patient-reported outcome instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: The qualitative research phase.. Alzheimers Dement. 12(1):75-84.
Leduc V, Théroux L, Dea D, Dufour R, Poirier J.  2016.  Effects of rs3846662 Variants on HMGCR mRNA and Protein Levels and on Markers of Alzheimer's Disease Pathology.. J Mol Neurosci. 58(1):109-19.
Florian H, Meier A, Gauthier S, Lipschitz S, Lin Y, Tang Q, Othman AA, Robieson WZ, Gault LM.  2016.  Efficacy and Safety of ABT-126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Study.. J Alzheimers Dis. 51(4):1237-47.
Gauthier S, Feldman HH, Schneider LS, Wilcock GK, Frisoni GB, Hardlund JH, Moebius HJ, Bentham P, Kook KA, Wischik DJ et al..  2016.  Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial.. Lancet. 388(10062):2873-2884.
Freitas C, Deschênes S, Au B, Smith K, Schmitz N.  2016.  Evaluating lifestyle and health-related characteristics of older adults with co-occurring depressive symptoms and cardiometabolic abnormalities.. Int J Geriatr Psychiatry. 31(1):66-75.
Sears C, Schmitz N.  2016.  The Relationship between Diabetes and Mental Health Conditions in an Aging Population.. Can J Diabetes. 40(1):4-5.
Leh SE, Kälin AM, Schroeder C, Park MTae M, M Chakravarty M, Freund P, Gietl AF, Riese F, Kollias S, Hock C et al..  2016.  Volumetric and shape analysis of the thalamus and striatum in amnestic mild cognitive impairment.. J Alzheimers Dis. 49(1):237-49.
Fletcher E, Villeneuve S, Maillard P, Harvey D, Reed B, Jagust W, DeCarli C.  2016.  β-amyloid, hippocampal atrophy and their relation to longitudinal brain change in cognitively normal individuals.. Neurobiol Aging. 40:173-80.
2015
Clyde M, Smith KJ, Gariépy G, Schmitz N.  2015.  Assessing the longitudinal associations and stability of smoking and depression syndrome over a 4-year period in a community sample with type 2 diabetes 24.. J Diabetes. 7(1):95-101.
Hibar DP, Stein JL, Renteria ME, Arias-Vasquez A, Desrivières S, Jahanshad N, Toro R, Wittfeld K, Abramovic L, Andersson M et al..  2015.  Common genetic variants influence human subcortical brain structures.. Nature. 520(7546):224-9.
Sankar T, M Chakravarty M, Bescos A, Lara M, Obuchi T, Laxton AW, McAndrews MPat, Tang-Wai DF, Workman CI, Smith GS et al..  2015.  Deep Brain Stimulation Influences Brain Structure in Alzheimer's Disease.. Brain Stimul. 8(3):645-54.
Rasmussen L, de Labio RW, Viani GA, Chen E, Villares J, Bertolucci P-H, Minett TS, Turecki G, Cecyre D, Drigo SA et al..  2015.  Differential Expression of Ribosomal Genes in Brain and Blood of Alzheimer's Disease Patients.. Curr Alzheimer Res. 12(10):984-9.
Benedet AL, Labbe A, Lemay P, Zimmer ER, Pascoal TA, Leuzy A, Mathotaarachchi S, Mohades S, Shin M, Dionne-Laporte A et al..  2015.  Epistasis analysis links immune cascades and cerebral amyloidosis.. J Neuroinflammation. 12:227.
Nazeri A, M Chakravarty M, Rotenberg DJ, Rajji TK, Rathi Y, Michailovich OV, Voineskos AN.  2015.  Functional consequences of neurite orientation dispersion and density in humans across the adult lifespan.. J Neurosci. 35(4):1753-62.
Nazeri A, Roostaei T, Sadaghiani S, M Chakravarty M, Eberly S, Lang AE, Voineskos AN.  2015.  Genome-wide variant by serum urate interaction in Parkinson's disease.. Ann Neurol. 78(5):731-41.
Voineskos AN, Winterburn JL, Felsky D, Pipitone J, Rajji TK, Mulsant BH, M Chakravarty M.  2015.  Hippocampal (subfield) volume and shape in relation to cognitive performance across the adult lifespan.. Hum Brain Mapp. 36(8):3020-37.
Bier N, Grenier S, Brodeur C, Gauthier S, Gilbert B, Hudon C, Lepage E, Ouellet M-C, Viscogliosi C, Belleville S.  2015.  Measuring the impact of cognitive and psychosocial interventions in persons with mild cognitive impairment with a randomized single-blind controlled trial: rationale and design of the MEMO+ study.. Int Psychogeriatr. 27(3):511-25.
Gariépy G, Thombs BD, Kestens Y, Kaufman JS, Blair A, Schmitz N.  2015.  The Neighbourhood Built Environment and Trajectories of Depression Symptom Episodes in Adults: A Latent Class Growth Analysis.. PLoS One. 10(7):e0133603.
Eskildsen SF, Coupé P, Fonov VS, Pruessner JC, D Collins L.  2015.  Structural imaging biomarkers of Alzheimer's disease: predicting disease progression.. Neurobiol Aging. 36 Suppl 1:S23-31.
2014
Luck T, Riedel-Heller SG, Luppa M, Wiese B, Bachmann C, Jessen F, Bickel H, Weyerer S, Pentzek M, König H-H et al..  2014.  A hierarchy of predictors for dementia-free survival in old-age: results of the AgeCoDe study.. Acta Psychiatr Scand. 129(1):63-72.
Schmitz N, Gariépy G, Smith KJ, Malla A, Boyer R, Strychar I, Lesage A, Wang JL.  2014.  Longitudinal relationships between depression and functioning in people with type 2 diabetes.. Ann Behav Med. 47(2):172-9.
Mondragón-Rodríguez S, Perry G, Luna-Muñoz J, Acevedo-Aquino MC, Williams S.  2014.  Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer's disease and Down syndrome.. Neuropathol Appl Neurobiol. 40(2):121-35.
Hye A, Riddoch-Contreras J, Baird AL, Ashton NJ, Bazenet C, Leung R, Westman E, Simmons A, Dobson R, Sattlecker M et al..  2014.  Plasma proteins predict conversion to dementia from prodromal disease.. Alzheimers Dement. 10(6):799-807.e2.

Pages